D-Index & Metrics Best Publications
Mark A. Prendergast

Mark A. Prendergast

University of Kentucky
United States

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Neurotransmitter
  • Neuron

His scientific interests lie mostly in Internal medicine, Endocrinology, Neurotoxicity, Pharmacology and Nicotine. His primary area of study in Endocrinology is in the field of Amygdala. His studies deal with areas such as Hippocampal formation, Glutamate receptor, Dopaminergic and NMDA receptor as well as Neurotoxicity.

The concepts of his Hippocampal formation study are interwoven with issues in Excitotoxicity and Cholinesterase. In his study, Acetylcholine receptor and Nicotinic acetylcholine receptor is inextricably linked to Antagonist, which falls within the broad field of Pharmacology. His Nicotine research incorporates elements of Anesthesia, Smoking cessation, Nicotinic agonist and Drug.

His most cited work include:

  • Molecular basis for interactions of HIV and drugs of abuse. (203 citations)
  • Molecular basis for interactions of HIV and drugs of abuse. (203 citations)
  • Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. (173 citations)

What are the main themes of his work throughout his whole career to date?

Mark A. Prendergast mainly focuses on Endocrinology, Internal medicine, Pharmacology, Neurotoxicity and NMDA receptor. Mark A. Prendergast studied Internal medicine and Ethanol that intersect with Alcohol. His work carried out in the field of Pharmacology brings together such families of science as Receptor, Antagonist, Nicotinic agonist, Nicotinic acetylcholine receptor and Nicotine.

The study incorporates disciplines such as Dizocilpine, Methamphetamine, Immunology and Caffeine in addition to Neurotoxicity. His studies in Immunology integrate themes in fields like Dopaminergic, Neuropathogenesis and Heroin. His research integrates issues of Glutamate receptor and Long-term potentiation in his study of NMDA receptor.

He most often published in these fields:

  • Endocrinology (47.86%)
  • Internal medicine (47.86%)
  • Pharmacology (32.48%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (47.86%)
  • Endocrinology (47.86%)
  • Antagonist (11.11%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Antagonist, Nicotine and Corticosterone. In most of his Internal medicine studies, his work intersects topics such as Neuron. His study in Endocrinology is interdisciplinary in nature, drawing from both NeuN and Receptor.

He has included themes like Pharmacology and Glucocorticoid in his Antagonist study. His Nicotine research focuses on subjects like Alcohol, which are linked to Naltrexone and Ethanol. Hippocampal formation is closely attributed to Neurotoxicity in his work.

Between 2013 and 2021, his most popular works were:

  • Ethanol withdrawal is required to produce persisting N-methyl-d-aspartate receptor-dependent hippocampal cytotoxicity during chronic intermittent ethanol exposure (24 citations)
  • Terfestatins B and C, New p-Terphenyl Glycosides Produced by Streptomyces sp. RM-5–8 (24 citations)
  • Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse. (23 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Neurotransmitter
  • Neuron

Mark A. Prendergast spends much of his time researching Biochemistry, Antagonist, Internal medicine, Endocrinology and Stereochemistry. His Biochemistry research is multidisciplinary, incorporating perspectives in Neurotoxicity and Hippocampus. His Antagonist research is multidisciplinary, incorporating elements of Varenicline, Smoking cessation, Corticosterone and Pharmacology.

His research on Internal medicine often connects related areas such as Craving. Endocrinology is closely attributed to Neuron in his work. His research in the fields of Glycoside overlaps with other disciplines such as Streptomyces, Hexuronic Acids, Rare sugar and Terphenyl Compounds.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

Clark A Briggs;David J Anderson;Jorge D Brioni;Jerry J Buccafusco;Jerry J Buccafusco.
Pharmacology, Biochemistry and Behavior (1997)

271 Citations

Molecular basis for interactions of HIV and drugs of abuse.

Avi Nath;Kurt F. Hauser;Kurt F. Hauser;Valerie Wojna;Valerie Wojna;Rosemarie M. Booze;Rosemarie M. Booze.
Journal of Acquired Immune Deficiency Syndromes (2002)

271 Citations

Acamprosate Inhibits the Binding and Neurotoxic Effects of Trans‐ACPD, Suggesting a Novel Site of Action at Metabotropic Glutamate Receptors

Barton R. Harris;Mark A. Prendergast;D. Alex Gibson;D. Trent Rogers.
Alcoholism: Clinical and Experimental Research (2002)

182 Citations

Lesions of the nucleus paragigantocellularis: effects on mating behavior in male rats.

David P. Yells;David P. Yells;Shelton E. Hendricks;Shelton E. Hendricks;Mark A. Prendergast;Mark A. Prendergast.
Brain Research (1992)

165 Citations

Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys

Mark A. Prendergast;William J. Jackson;Alvin V. Terry;Michael W. Decker.
Psychopharmacology (1998)

139 Citations

Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-D-aspartate receptors.

M.A Prendergast;B.R Harris;P.J Mullholland;J.A Blanchard.
Neuroscience (2004)

133 Citations

Repeated Exposures to Subthreshold Doses of Chlorpyrifos in Rats: Hippocampal Damage, Impaired Axonal Transport, and Deficits in Spatial Learning

A. V. Terry;J. D. Stone;J. J. Buccafusco;D. W. Sickles.
Journal of Pharmacology and Experimental Therapeutics (2003)

133 Citations

The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors.

Barton R. Harris;D. Alex Gibson;Mark A. Prendergast;John A. Blanchard.
Alcoholism: Clinical and Experimental Research (2003)

130 Citations

ABT-089 (2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride): II. A Novel Cholinergic Channel Modulator with Effects on Cognitive Performance in Rats and Monkeys

Michael W. Decker;Anthony W. Bannon;Peter Curzon;Karen L. Gunther.
Journal of Pharmacology and Experimental Therapeutics (1997)

127 Citations

Fluoxetine-induced inhibition of male rat copulatory behavior: modification by lesions of the nucleus paragigantocellularis.

David P. Yells;Mark A. Prendergast;Shelton E. Hendricks;Motoyuki Nakamura.
Pharmacology, Biochemistry and Behavior (1994)

120 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark A. Prendergast

Avindra Nath

Avindra Nath

National Institutes of Health

Publications: 29

Roger L. Papke

Roger L. Papke

University of Florida

Publications: 18

Edward D. Levin

Edward D. Levin

Duke University

Publications: 15

Shilpa Buch

Shilpa Buch

University of Nebraska Medical Center

Publications: 13

Craig A. Erickson

Craig A. Erickson

Cincinnati Children's Hospital Medical Center

Publications: 12

Jan G. Veening

Jan G. Veening

Radboud University Nijmegen

Publications: 12

Dieter J. Meyerhoff

Dieter J. Meyerhoff

University of California, San Francisco

Publications: 12

Joan W. Berman

Joan W. Berman

Albert Einstein College of Medicine

Publications: 12

Berend Olivier

Berend Olivier

Utrecht University

Publications: 12

Lique M. Coolen

Lique M. Coolen

Kent State University

Publications: 12

Eliseo A. Eugenin

Eliseo A. Eugenin

The University of Texas Medical Branch at Galveston

Publications: 11

Sabita Roy

Sabita Roy

University of Miami

Publications: 11

Adolf Pfefferbaum

Adolf Pfefferbaum

Stanford University

Publications: 11

Oksana Lockridge

Oksana Lockridge

University of Nebraska Medical Center

Publications: 11

Craig R. Rush

Craig R. Rush

University of Kentucky

Publications: 10

Rosemarie M. Booze

Rosemarie M. Booze

University of South Carolina

Publications: 10

Trending Scientists

Alessandro Cigno

Alessandro Cigno

University of Florence

Andreas Türler

Andreas Türler

University of Bern

Yeoung-Sang Yun

Yeoung-Sang Yun

Jeonbuk National University

Joel K. W. Yang

Joel K. W. Yang

Singapore University of Technology and Design

Lev L. Kisselev

Lev L. Kisselev

Engelhardt Institute of Molecular Biology

Marcel Méchali

Marcel Méchali

University of Montpellier

Alex J. Ball

Alex J. Ball

University of New England

Kalyan Das

Kalyan Das

Rega Institute for Medical Research

Susana López

Susana López

National Autonomous University of Mexico

Randall J. Cohrs

Randall J. Cohrs

University of Colorado Anschutz Medical Campus

Roberta Vecchi

Roberta Vecchi

University of Milan

Michael P. Schön

Michael P. Schön

University of Göttingen

Christopher Linington

Christopher Linington

University of Glasgow

George Steinmetz

George Steinmetz

University of Michigan–Ann Arbor

Jon Christopher Wikne

Jon Christopher Wikne

University of Oslo

Xiaohu Yang

Xiaohu Yang

Shanghai Jiao Tong University

Something went wrong. Please try again later.